scholarly journals Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer

2021 ◽  
Author(s):  
Kazuya Takeda ◽  
Haruo Matsushita ◽  
Rei Umezawa ◽  
Takaya Yamamoto ◽  
Yojiro Ishikawa ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Hyperfractionated Radiotherapy

scholarly journals Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: A phase I and II study

1997 ◽  
Vol 114 (5) ◽  
pp. 811-816 ◽  
Author(s):  
Cameron D. Wright ◽  
John C. Wain ◽  
Thomas J. Lynch ◽  
Noah C. Choi ◽  
Michael L. Grossbard ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Phase I ◽  
Induction Therapy ◽  
Hyperfractionated Radiotherapy ◽  
Phase I And Ii

Considerations in Dysphagia Management Following Esophagectomy

2016 ◽  
Vol 1 (13) ◽  
pp. 169-176
Author(s):  
Lisa M. Evangelista ◽  
James L. Coyle
Keyword(s):  
Esophageal Cancer ◽  
Minimally Invasive ◽  
Minimally Invasive Surgical Procedures ◽  
Esophageal Resection ◽  
Minimally Invasive Surgical ◽  
Operative Complications ◽  
Swallowing Difficulties ◽  
Epidemiological Impact ◽  
Invasive Techniques ◽  
Management Of Dysphagia

Esophageal cancer is the sixth leading cause of death from cancer worldwide. Esophageal resection is the mainstay treatment for cancers of the esophagus. While curative, surgical resection may result in swallowing difficulties that require intervention from speech-language pathologists (SLPs). Minimally invasive surgical procedures for esophageal resection have aimed to reduce morbidity and mortality associated with more invasive techniques. Both intra-operative and post-operative complications, regardless of the surgical approach, can result in dysphagia. This article will review the epidemiological impact of esophageal cancers, operative complications resulting in dysphagia, and clinical assessment and management of dysphagia pertinent to esophageal resection.

Sign in / Sign up

Export Citation Format

Share Document